Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

被引:1252
作者
Wetterslev, Jorn [1 ]
Thorlund, Kristian [1 ]
Brok, Jesper [1 ]
Gluud, Christian [1 ]
机构
[1] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Interven Res, Copenhagen Trial Unit,Dept 3344, DK-2100 Copenhagen, Denmark
关键词
meta-analysis; cumulative meta-analysis; trial sequential monitoring boundaries; type I error; type II error; heterogeneity; information size; sample size;
D O I
10.1016/j.jclinepi.2007.03.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: Cumulative meta-analyses are prone to produce spurious P < 0.05 because of repeated testing of significance as trial data accumulate. Information size in a meta-analysis should at least equal the sample size of an adequately powered trial. Trial sequential analysis (TSA) corresponds to group sequential analysis of a single trial and may be applied to meta-analysis to evaluate the evidence. Study Design and Setting: Six randomly selected neonatal meta-analyses with at least five trials reporting a binary outcome were examined. Low-bias heterogeneity-adjusted information size and information size determined from an assumed intervention effect of 15% were calculated. These were used for constructing trial sequential monitoring boundaries. We assessed the cumulative z-curves' crossing of P = 0.05 and the boundaries. Results: Five meta-analyses showed early potentially spurious P < 0.05 values. In three significant meta-analyses the cumulative z-curves crossed both boundaries, establishing firm evidence of an intervention effect. In two nonsignificant meta-analyses the cumulative z-curves crossed P = 0.05, but never the boundaries, demonstrating early potentially spurious P < 0.05 values. In one nonsignificant meta-analysis the cumulative z-curves never crossed P = 0.05 or the boundaries. Conclusion: TSAs may establish when firm evidence is reached in meta-analysis. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 75
页数:12
相关论文
共 46 条
  • [1] ALSNIELSEN B, 2004, 12 INT COCHR C OTT, P88
  • [2] Meta-analysis, Simpson's paradox, and the number needed to treat
    Altman D.G.
    Deeks J.J.
    [J]. BMC Medical Research Methodology, 2 (1) : 1 - 5
  • [3] [Anonymous], 12 COCHR C BRIDG GAP
  • [4] SEQUENTIAL ANALYSIS IN THERAPEUTIC TRIALS
    ARMITAGE, P
    [J]. ANNUAL REVIEW OF MEDICINE, 1969, 20 : 425 - +
  • [5] BARRINGTON KJ, 2000, COCHRANE DB SYST REV, V2
  • [6] Uncertainty of the time of first significance in random effects cumulative meta-analysis
    Berkey, CS
    Mosteller, F
    Lau, J
    Antman, EM
    [J]. CONTROLLED CLINICAL TRIALS, 1996, 17 (05): : 357 - 371
  • [7] Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis
    Bjelakovic, G
    Nikolova, D
    Simonetti, RG
    Gluud, C
    [J]. LANCET, 2004, 364 (9441) : 1219 - 1228
  • [8] Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
    Bjelakovic, Goran
    Nikolova, Dimitrinka
    Gluud, Lise Lotte
    Simonetti, Rosa G.
    Gluud, Christian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08): : 842 - 857
  • [9] BRION LP, 2003, COCHRANE DB SYST REV, V4
  • [10] BROK J, 2006, CLIN TRIALS, V3, P241